Netherlands
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 40.28 B |
Jan. 14, 2025 | USD 673.61 | 1.66% |
|
Netherlands |
|
2 |
USD 23.51 B |
Jan. 14, 2025 | USD 24.98 | -2.69% |
|
Netherlands |
|
3 |
USD 10.13 B |
Jan. 14, 2025 | USD 45.57 | -0.94% |
|
Netherlands |
|
4 |
USD 8.33 B |
Jan. 14, 2025 | USD 139.49 | 1.47% |
|
Netherlands |
|
5 |
USD 2.67 B |
Jan. 14, 2025 | USD 39.01 | -3.56% |
|
Netherlands |
|
6 |
USD 2.62 B |
Jan. 14, 2025 | USD 121.51 | 5.06% |
|
Netherlands |
|
7 |
USD 2.53 B |
Jan. 14, 2025 | USD 23.67 | -3.70% |
|
Netherlands |
|
8 |
USD 1.33 B |
Jan. 14, 2025 | USD 22.92 | 2.26% |
|
Netherlands |
|
9 |
USD 867.73 M |
Jan. 14, 2025 | USD 16.00 | -2.50% |
|
Netherlands |
|
10 |
USD 706.98 M |
Jan. 14, 2025 | USD 13.23 | -4.06% |
|
Netherlands |
|
11 |
USD 673.99 M |
Jan. 14, 2025 | USD 9.93 | 5.98% |
|
Netherlands |
|
12 |
USD 239.35 M |
Jan. 14, 2025 | USD 2.26 | -0.44% |
|
Netherlands |
|
13 |
USD 25.77 M |
Jan. 14, 2025 | USD 0.98 | -1.01% |
|
Netherlands |
The Health Care company in Netherlands with the highest Market Capitalization is argenx SE (Brussels Stock Exchange: ARGX.BR) at USD 40.28 B.
The Health Care company in Netherlands with the lowest Market Capitalization is LAVA Therapeutics N.V. (NasdaqGS: LVTX) at USD 25.77 M.
The top 10 Health Care companies in Netherlands by Market Capitalization are argenx SE, Koninklijke Philips N.V., Qiagen N.V., IMCD N.V., Merus N.V., Redcare Pharmacy NV, NewAmsterdam Pharma Company N.V., Corbion N.V., Pharvaris N.V. and uniQure N.V..
The bottom 10 Health Care companies in Netherlands by Market Capitalization are LAVA Therapeutics N.V., ProQR Therapeutics N.V., Pharming Group N.V., uniQure N.V., Pharvaris N.V., Corbion N.V., NewAmsterdam Pharma Company N.V., Redcare Pharmacy NV, Merus N.V. and IMCD N.V..